ORAGENICS INC (OGEN)
About ORAGENICS INC
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2023
- $37.7K
- Net income
- -$9.8M
- Total assets
- $10.1M
- Market cap
- $2.7M
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $9.4M
- Operating income
- -$9.4M
- Net income
- -$9.8M
- EPS (basic)
- $-4.56
- EPS (diluted)
- $-4.56
Balance sheet
- Total assets
- $10.1M
- Current assets
- $10.1M
- Total liabilities
- $1.8M
- Current liabilities
- $1.8M
- Shareholders’ equity
- $8.3M
Cash flow
- Operating cash flow
- -$9.2M
- Investing cash flow
- -$7.5M
- Financing cash flow
- $16.8M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $2.7M
- EPS (diluted)
- $-4.56
- Shares outstanding
- 5.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 3, 2003
Oragenics Inc (OGEN) Stock Price
- Reported a net loss of $9.8M in FY2023.
- Trading 87% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ORAGENICS INC.
Write a review
News about ORAGENICS INC
News & sentiment via Polygon.io
Oragenics Inc: frequently asked questions
Is Oragenics Inc an American company?
Oragenics Inc is a US-based company headquartered in Lakewood Ranch, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Oragenics Inc headquartered?
Oragenics Inc is headquartered in Lakewood Ranch, Florida, United States.
Is Oragenics Inc publicly traded?
Yes — Oragenics Inc is a publicly traded company. Its stock trades under the ticker symbol OGEN on the NYSE.
What does Oragenics Inc do?
Oragenics Inc is an American Pharmaceuticals company in the Health & Beauty sector.
